Skip to main content

Barwon Health / Research

(03) 4215 0000

Cancer - Haematology and Oncology Trials Team

Cancer Services at Barwon Health has a long and distinguished history conducting clinical research through a dedicated clinical trials unit established in 1997 at the Andrew Love Cancer Centre (ALCC) – the Haematology and Oncology Trials Team (HOTT).

The unit conducts cooperative, investigator-initiated and sponsored phase 1b-III/IV studies across a wide range of haematological malignancies and solid tumours. Trials are selected by investigators according to scientific and ethical merit as well as clinical need, enabling local patients to access novel therapies in the first-line treatment setting or beyond second-line when patients are less likely to have readily available and accessible standard of care treatment options.

Our clinical trial portfolio has grown significantly in recent years and our aim is to provide patients with increasing access to clinical trials in line with the state government’s Victorian Cancer Plan.

Our research activity benefits our regional patients, minimising their requirement to travel to larger metropolitan centres to access the latest novel therapies.

Research Areas

Collaborating Organisations

Victorian Comprehensive Cancer Centre (VCCC)

Cancer Council Victoria (CCV)  Cancer Trials Australia (CTA) National Health and Medical Research Council (NHMRC) Australasian Leukaemia & Lymphoma Group (ALLG)

Australian Lung Cancer Trials Group (ALTG)

Breast Cancer Trials (BCT) ANZ Gynaecological Oncology Group (ANZGOG) ANZ Urogenital and Prostate Cancer Trials Group (ANZUP) Clinical Oncology Society of Australia (COSA)

Medical Oncology Group of Australia (MOGA)

The Trans Tasman Radiation Oncology Group (TROG) Australasian Gastro-Intestinal Trials Group (AGITG)    

 

Research Team

Research Staff

Director

  • A/Professor Philip Campbell – Director of Cancer Service/Head of Haematology, MB ChB FRCP FRACP FRCPath FRCPA

Haematology Investigators

  • A/Professor Philip Campbell – Head of Haematology, MB ChB FRCP FRACP FRCPath FRCPA
  • Dr Adam Friebe, MBBS FRACP FRCPA
  • Dr David Kipp, MBBS BMedSc FRACP FRCPA
  • Dr Sumita Ratnasingham, AdvDipMedSci BMedSci MBBS FRACP FRCPA
  • Dr Hannah Rose, MBBS (Hons) FRACP

Medical Oncology Investigators

  • Dr David Campbell – Head of Medical Oncology, MBBS FRACP
  • Dr Patricia Banks, MB BS Bsc(Hons) FRACP
  • Dr Adam Broad, MBBS FRACP
  • Dr Anna Lomax, MBBS BSc FRACP
  • Dr Caitlin Murphy, MB BS(Hons) BA FRACP
  • Dr Inger Olesen, MBBS (Hons) FRACPn
  • Dr Madhu Singh, MBBS FRACP
  • Dr Karen White, MBBS FRACP
  • Dr Shu Fen Wong, BMedSci MBBS FRACO Master of Applied Science

Radiation Oncology Investigators

  • Dr Graham Pitson - Head of Radiation Oncology, MBBS FRANZCR
  • Dr Michael Francis, MBBS FRANZCR
  • Dr Andrew Hui, MBBS FRANZCR Mmed (clin epi)
  • Dr Maitham Mathlum, MBchB FRANZCR

Haematology & Oncology Trials Team

  • Dr Lea-Anne Harrison – Clinical Trials Manager
  • Damon Arezzolo – Clinical Trial Coordinator
  • Scott Betteridge – Clinical Trial Coordinator
  • Sonja Gauci – Clinical Trial Coordinator
  • Melainie Giddings – Clinical Trial Coordinator
  • Katrina Golden – Clinical Trial Coordinator
  • Sharon Jones – Clinical Trial Coordinator
  • Mandy McPhee – Clinical Trial Coordinator
  • Elesha Parigi – Clinical Trial Coordinator
  • Iwona Riches – Clinical Trial Coordinator
  • Bianca Sawyer – Clinical Trial Coordinator
  • Tina Smith – Clinical Trial Coordinator
  • Adele Stronach – Clinical Trial Coordinator
  • Amy Dang – Data Manager
  • Andrea Dozzi – Administrative Assistant
  • Katherine Snowden – Clinical Trial Pharmacist

Research Students

SKILLED Interns for 2020:

  • Mitchell Clements – Clinical Trials Assistant
  • Stephanie Cowdery – Clinical Trials Coordinator

Research News

Featured Publications

ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia. [NOTE - Full text for Barwon Health staff; public can view abstract]. Ghia P, Pluta A, Wach M, Lysak D, Kozak T, Simkovic M, Kaplan P, Kraychok I, Illes A, de la Serna J, Dolan S, Campbell P et al. Journal of Clinical Oncology 2020;38(25):2849-2861. 

Cited By


Support Our Research

Participate in a Clinical Trial

To find out about Clinical Trials currently underway at Barwon Health, click here.

Donate

Clinical trials require ongoing investment and there are several ways to support this amazing work.

You can make a donation today and contribute to an item on our research wish list, consider a bequest in your will, or establish a lasting legacy fund in your name. No matter what size, your philanthropic support with deliver an immediate impact.

To donate now or for more information and further discuss your support, please contact the Barwon Health Foundation.

 

Last Modified: Thursday, 24 September 2020

Research Leads

BHFJune0063

A/Professor Philip Campbell
Director of Cancer Services and Head of Haematology

BHFJune0064

Dr David Campbell
Head of Medical Oncology

Dr Graeme Pitson
Head of Radiation Oncology

BHFJune0062

Dr Lea-Anne Harrison
Haematology and Oncology Trials Team Manager

Andrew Love Cancer Centre
70 Swanston Street
Geelong VIC 3220

Ph (03) 4215 2758
Fax (03) 4215 2835

[email protected]
[email protected]
[email protected]